Product Name

  • Name

    MABUTEROL

  • EINECS 1312995-182-4
  • CAS No. 56341-08-3
  • Article Data3
  • CAS DataBase
  • Density 1.278 g/cm3
  • Solubility
  • Melting Point 85-87oC
  • Formula C13H18ClF3N2O
  • Boiling Point 375.9 °C at 760 mmHg
  • Molecular Weight 310.747
  • Flash Point 181.1 °C
  • Transport Information
  • Appearance
  • Safety
  • Risk Codes
  • Molecular Structure Molecular Structure of 56341-08-3 (MABUTEROL)
  • Hazard Symbols
  • Synonyms 4-Amino-alpha-((tert-butylamino)methyl)-3-chloro-5-(trifluoromethyl)benzyl alcohol;Ambuterol;Mabuterolum;4-Amino-3-chloro-alpha-[[(1,1-dimethylethyl)amino]methyl]-5-(trifluoromethyl)benzenemethanol;Broncholin;
  • PSA 58.28000
  • LogP 4.33460

Mabuterol hydrochloride Chemical Properties

Product Name: KF-868 (CAS NO.54240-36-7)


Molecular Formula: C13H18ClF3N2O.HCl
Molecular Weight: 347.2g/mol
Mol File: 54240-36-7.mol
Appearance: A solid
Boiling point: 375.9°Cat760mmHg
Flash Point: 181.1 °C
Enthalpy of Vaporization: 65.77 kJ/mol
Vapour Pressure: 2.57E-06 mmHg at 25°C
H-Bond Donor: 4
H-Bond Acceptor: 6

Mabuterol hydrochloride Toxicity Data With Reference

Organism Test Type Route Reported Dose (Normalized Dose) Effect Source
dog LD50 intravenous 27500ug/kg (27.5mg/kg) BEHAVIORAL: ALTERED SLEEP TIME (INCLUDING CHANGE IN RIGHTING REFLEX)

BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD

LUNGS, THORAX, OR RESPIRATION: DYSPNEA		 Arzneimittel-Forschung. Drug Research. Vol. 34, Pg. 1680, 1984.
dog LD50 oral 229mg/kg (229mg/kg) BEHAVIORAL: ALTERED SLEEP TIME (INCLUDING CHANGE IN RIGHTING REFLEX)

BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD

LUNGS, THORAX, OR RESPIRATION: DYSPNEA		 Arzneimittel-Forschung. Drug Research. Vol. 34, Pg. 1680, 1984.
human TDLo oral 1143ng/kg (0.001143mg/kg) BEHAVIORAL: TREMOR

BEHAVIORAL: HEADACHE		 Arzneimittel-Forschung. Drug Research. Vol. 34, Pg. 1697, 1984.
human TDLo oral 60ug/kg/6W (0.06mg/kg) BEHAVIORAL: TREMOR

CARDIAC: PULSE RATE INCREASE WITHOUT FALL IN BP		 Arzneimittel-Forschung. Drug Research. Vol. 34, Pg. 1699, 1984.
mouse LD50 intraperitoneal 60mg/kg (60mg/kg) BEHAVIORAL: ALTERED SLEEP TIME (INCLUDING CHANGE IN RIGHTING REFLEX)

BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD

LUNGS, THORAX, OR RESPIRATION: DYSPNEA		 Arzneimittel-Forschung. Drug Research. Vol. 34, Pg. 1680, 1984.
mouse LD50 intravenous 36500ug/kg (36.5mg/kg)   Arzneimittel-Forschung. Drug Research. Vol. 34, Pg. 652, 1984.
mouse LD50 oral 200mg/kg (200mg/kg) BEHAVIORAL: ALTERED SLEEP TIME (INCLUDING CHANGE IN RIGHTING REFLEX)

BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD

LUNGS, THORAX, OR RESPIRATION: DYSPNEA		 Arzneimittel-Forschung. Drug Research. Vol. 34, Pg. 1680, 1984.
mouse LD50 subcutaneous 113mg/kg (113mg/kg) BEHAVIORAL: ALTERED SLEEP TIME (INCLUDING CHANGE IN RIGHTING REFLEX)

LUNGS, THORAX, OR RESPIRATION: DYSPNEA

BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD		 Arzneimittel-Forschung. Drug Research. Vol. 34, Pg. 1680, 1984.
rabbit LD50 intravenous 18300ug/kg (18.3mg/kg) BEHAVIORAL: ALTERED SLEEP TIME (INCLUDING CHANGE IN RIGHTING REFLEX)

LUNGS, THORAX, OR RESPIRATION: DYSPNEA

BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD		 Arzneimittel-Forschung. Drug Research. Vol. 34, Pg. 1680, 1984.
rabbit LD50 oral 243mg/kg (243mg/kg) BEHAVIORAL: ALTERED SLEEP TIME (INCLUDING CHANGE IN RIGHTING REFLEX)

LUNGS, THORAX, OR RESPIRATION: DYSPNEA

BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD		 Arzneimittel-Forschung. Drug Research. Vol. 34, Pg. 1680, 1984.
rat LD50 intraperitoneal 76300ug/kg (76.3mg/kg) BEHAVIORAL: ALTERED SLEEP TIME (INCLUDING CHANGE IN RIGHTING REFLEX)

LUNGS, THORAX, OR RESPIRATION: DYSPNEA

BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD		 Arzneimittel-Forschung. Drug Research. Vol. 34, Pg. 1680, 1984.
rat LD50 intravenous 26400ug/kg (26.4mg/kg) BEHAVIORAL: ALTERED SLEEP TIME (INCLUDING CHANGE IN RIGHTING REFLEX)

LUNGS, THORAX, OR RESPIRATION: DYSPNEA

BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD		 Arzneimittel-Forschung. Drug Research. Vol. 34, Pg. 1680, 1984.
rat LD50 oral 306mg/kg (306mg/kg) BEHAVIORAL: ALTERED SLEEP TIME (INCLUDING CHANGE IN RIGHTING REFLEX)

BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD

LUNGS, THORAX, OR RESPIRATION: DYSPNEA		 Arzneimittel-Forschung. Drug Research. Vol. 34, Pg. 1680, 1984.
rat LD50 subcutaneous 117mg/kg (117mg/kg) BEHAVIORAL: ALTERED SLEEP TIME (INCLUDING CHANGE IN RIGHTING REFLEX)

BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD

LUNGS, THORAX, OR RESPIRATION: DYSPNEA		 Arzneimittel-Forschung. Drug Research. Vol. 34, Pg. 1680, 1984.

Mabuterol hydrochloride Safety Profile

Poison by intravenous route. An experimental teratogen. Experimental reproductive effects. When heated to decomposition it emits toxic fumes of F−, NOx, and HCl.

Mabuterol hydrochloride Specification

 KF-868 ,its CAS NO. is 54240-36-7,the synonyms is Mabuterolhcl ; Benzenemethanol, 4-amino-3-chloro-a-[[(1,1-dimethylethyl)amino]methyl]-5-(trifluoromethyl)-, monohydrochloride (9ci) ; Broncholin ; Dl-mabuterol hydrochloride ; KF868 (pharmaceutical) .

Related Products

Hot Products

Post buying leads

About|Contact|Cas|Product Name|Molecular|Country|Encyclopedia

Message|New Cas|MSDS|Service|Advertisement|CAS DataBase|Article Data|Manufacturers | Chemical Catalog

©2008 LookChem.com,License: ICP

NO.:Zhejiang16009103

complaints:service@lookchem.com Desktop View